Loading patent…
AssigneesTaki Chemical Co., Ltd., National Institute for Material Science President
InventorsJunzo Tanaka, Masanori Kikuchi, Kimihiro Miyamoto, Shuji Suwa, Shunji Ichikawa, Etsuro Yokoyama, Soichi Shono, Takao Okada, Yukari Imamura, Kazuo Takakuda, Yoshihisa Koyama, Shigeo Tanaka, Noriaki Shirahama, Takatoshi Itoh
Estimating the term…
The followings are disclosed herein: a biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and ε-caprolactone; a biomaterial for the induction of osteoanagenesis, characterized in that a periosteum is attached to the biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and ε-caprolactone; and a biomaterial for the prevention of adhesion comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and ε-caprolactone where the molar ratio of lactic acid, glycolic acid and ε-caprolactone is within a range of 5-90:3-75:5-40.
A biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and ε-caprolactone, wherein the ε-caprolactone content in the copolymer is within a range of about 1 to abut 45 molar % and the glycolic acid content in the copolymer is within a range of about 5 to about 70 molar %.
A biomaterial for the induction of osteoanagenesis, characterized in that a periosteum is attached to the biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and ε-caprolactone.
A biomaterial for the prevention of adhesion comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and ε-caprolactone where the molar ratio of lactic acid, glycolic acid and ε-caprolactone is within a range of 5-90:3-75:5-40.
Dependencies are inferred from the claim text.